Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-K
Source: 0001640334-25-001300
Chunk: 294

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-K
Item: Item 2
Chunk 294
---
 lease payments was measured using an incremental borrowing rate of 6.00% per annum as of December 31, 2024 and 2023. Future minimum lease payments under operating leases at December 31, 2024 were as follows: 2025 $27,780 Thereafter  - Total  27,780 Less Imputed interest  (882)Operating lease liabilities $26,898  The Company recognized total lease expense of $27,780 and $26,280 for the years ended December 31, 2024 and 2023, respectively.

NOTE 8 - SUBSEQUENT EVENTS The Company has evaluated subsequent events that have occurred after the date of the balance sheet through the date of issuance of these financial statements and determined that no subsequent event requires recognition or disclosure to the financial statements.

 F-14